0.50Open0.32Pre Close50 Volume454 Open Interest73.00Strike Price2.38KTurnover49.02%IV5.05%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.45Extrinsic Value100Contract SizeAmericanOptions Type-0.1695Delta0.0668Gamma218.31Leverage Ratio-0.1276Theta-0.0013Rho-37.00Eff Leverage0.0195Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet